VAERS reports by lot

Merck HPV lot W026977: VAERS reports

26 VAERS reports list lot W026977 as a Merck HPV vaccine, received between 2023-03-16 and 2024-08-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
0%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1532%
Gastrointestinal613%
General / Systemic (non-local)613%
Injection-site / Local reaction613%
Cardiac / Cardiovascular49%
Dermatological (non-injection-site)36%
Allergic / Anaphylactic24%
Respiratory24%
Musculoskeletal24%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 10).

Texas5
California4
Alabama3
Florida3
Utah2
North Carolina1
Michigan1
Arkansas1
West Virginia1
South Carolina1

Reports by month received

2023-031
2023-041
2023-054
2023-067
2023-072
2023-081
2023-093
2023-121
2024-021
2024-041
2024-062
2024-071
2024-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.